Continuous Growth in Population and the Resulting Rise in Demand for Convenience and Processed Food Offers Opportunities for Market Growth of Food Safety Testing
Chicago, Nov. 01, 2022 (GLOBE NEWSWIRE) — According to MarketsandMarkets™, the “Food Safety Testing Market by Target Tested, Technology (Traditional and Rapid), Food Tested (Meat, Poultry, Seafood, Dairy, Processed Foods, Fruits & Vegetables, and Cereals & grains) and Region – Global Forecast to 2027″, published by MarketsandMarkets, the market for Food safety testing is estimated at USD 21.1 billion in 2022; it is projected to grow at a CAGR of 8.1% to reach USD 31.1 billion by 2027.
Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=365
The meat, poultry, and seafood segment by food tested is projected to achieve the highest CAGR growth in the food safety testing market.
One of the main societal concerns has been the safety of meat and meat products, which is defined by a number of problems related to either microbial infections or other problems (whether biological or not), such as food additives, chemical residues, genetically modified organisms, and microbial pathogens. Factors such as an increase in the number of consumers at risk for infection, and increased consumer interest, awareness, and scrutiny have all been identified as potential explanations for the rising meat safety concerns of recent years. One of the major factors that drive the growth of the seafood testing service industry is the high demand for seafood products, such as crustaceans, shrimps, crabs, lobsters, tuna, marlin, and swordfish, due to their nutritional values such as the presence of omega fatty acids and other essential nutrients.
Browse in-depth TOC on “Food Safety Testing Market“
337 – Tables
82 – Figures
269 – Pages
By target tested, the pathogen segment is projected to account for the highest market share in the food safety testing market.
Pathogen is the main cause of food contamination that leads to disease-infected hosts. They form a major part of food contaminants. According to WHO, Salmonella, Campylobacter, and enterohaemorrhagic Escherichia coli are some of the most common foodborne pathogens that affect millions of people annually, sometimes with severe and fatal results. Increasing foodborne diseases, coupled with the growing importance of food safety, have increased the demand for food safety testing services significantly over the past few years.
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=365
The traditional technology segment is projected to account for the second-largest market share in the food safety testing market over the forecast period.
Traditional technology finds its application in microbial assays, visual inspection, and culturing methods. Enzyme-linked immunosorbent assay (ELISA) and culturing methods require a minimum of two to three days. The only major drawback of this technology is that it is time-consuming. However, the traditional segment is predicted to grow gradually as regular tests are an indispensable part of common food safety testing laboratories.
Europe is projected to achieve the highest market share in the food safety testing market.
High food safety regulations that safeguard consumer health and promote the efficient operation of the European market have been established by the foundation of the European Union’s (EU) food policy. Different foodborne disease evidence and food contaminations have reduced the confidence of consumers in the ability of the food industry and food safety authorities. Hence, the food safety policies in Europe follow the “from farm to fork” strategy—testing conducted right from the raw material procurement stage to the final distribution stage.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=365
Key Market Players
The key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), TÜV SÜD (Germany), TÜV Nord Group (Germany), NEOGEN Corporation (US), Mérieux NutriSciences (US), AsureQuality (New Zealand), FoodChain ID (US), R J Hill Laboratories Limited (New Zealand), Microbac Laboratories, Inc. (US), Romer Labs (Austria), and Symbio Laboratories (Australia). These players in this market are focusing on increasing their presence through agreements and collaborations. These companies have a strong presence in North America, Asia Pacific and Europe. They also have manufacturing facilities along with strong distribution networks across these regions.
Related Reports:
Bacteriological Testing Market by Bacteria (Coliform, Salmonella, Campylobacter, Legionella, Listeria), Technology (Traditional, Rapid), End-use Industry (Food & Beverage, Water, Pharmaceutical, Cosmetics), Component, and Region – Global Forecast 2022
Dairy Testing Market by Type (Safety (Pathogens, Adulterants, Pesticides), Quality), Technology (Traditional, Rapid), Product (Milk & Milk Powder, Cheese, Butter & Spreads, Infant Foods, ICE Cream & Desserts, Yogurt), and by Region – Global Forecast to 2026
GMO Testing Market by Trait (Stacked, Herbicide Tolerance, Insect Resistance), Technology (Polymerase Chain Reaction, Immunoassay), Crop Tested, Processed Food Tested, and Region – Global Forecast to 2022
Browse Adjacent Reports @ Food and Beverage Market Research Reports & Consulting
Yahoo Finance's Anjalee Khemlani breaks down CVS third-quarter earnings, the impact from an opioid lawsuit, and the growth in pharmacy and health care services.
President and CEO Michael Morrissey said the deals tap the company's balance sheet and share risks with its partners.
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Horizon Therapeutics (NASDAQ: HZNP), a biopharmaceutical company that specializes in rare, autoimmune, and inflammatory diseases, saw its shares jump 11.32% on Wednesday after the company released its third-quarter earnings. Horizon's third-quarter numbers were mostly down year over year. Net income was listed at $135.8 million, down 58% year over year, and earnings per share of $0.58 was down 58% compared to the same period in 2021.
Surface Oncology Inc (NASDAQ: SURF) observed confirmed partial responses from SRF388 monotherapy data in non-small cell lung cancer (NSCLC) patients. The partial responses were observed in patients treated at or above the recommended Phase 2 dose (22% ORR (2/9)), which includes 100% (2/2) of patients with squamous NSCLC. Additionally, a patient with adenocarcinoma has experienced durable disease stabilization, ongoing for more than 56 weeks. Surface has initiated a single-arm Phase 2 study evalu
J&J wanted a deal to boost its medical-device division, which will become more important after the company sheds its consumer-health business.
Geoffrey Seymour discovered blood in his stool just before his 41st birthday, which turned out to be stage four cancer
Pointing to a crowded market, a Durham drug developer has discontinued one of its clinical programs, allowing the company to shift up to $100 million toward other programs.
California is now an “emerging hotspot” for the family of variants, known to be the most immune evasive and transmissible yet, according to experts.
The former Bachelorette opens up for the first time about her "unexpected" journey with newborn son Jones
Is Pfizer stock a buy or a sell as it aims to gain the first approval for a maternal SRV shot? Is PFE stock a buy or a sell right now?
Inflation is 8.3%, medical costs are up by 5.4%, the average hospital stay for Medicare patients is $13,600 and the most recent estimate is that people aged 65 will pay $315,000 for medical care during their retirement years. So what's … Continue reading → The post Here's Why Retirees Can Breathe a Sigh of Relief appeared first on SmartAsset Blog.
When it comes to Medicare, understanding your healthcare needs and finding the right coverage are essential. But as you get close to or enter retirement, making decisions about your health can be overwhelming. To make the process a little easier, Vanguard … Continue reading → The post Vanguard's 3 Steps to Maximizing Your Medicare Coverage appeared first on SmartAsset Blog.
Some techniques that rejuvenate blood may hold promise for improving the performance of the aging human brain in the future. But there's plenty we can do on our own.
Many of us take different dietary supplements every day, but while we're simply trying to improve our health and wellness, we could inadvertently be putting ourselves at risk. The U.S. Food and Drug Administration (FDA) does not regulate supplements the same way it regulates medication, which could lead to more safety issues that you may realize. The agency regularly updates consumers about risks associated with supplements on the market, as well as those that have been pulled. Now, the FDA is a
By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT Commercialization Plans for Motixafortide (APHEXDA®) BioLineRx Ltd. (NASDAQ:BLRX) submitted its New Drug Application (NDA) to the FDA on September 9, 2022 for Motixafortide (now branded Aphexda) in stem cell mobilization for multiple myeloma patients undergoing autologous bone marrow transplantation. Since then, BioLineRx
When Claudia Siegel got a stomach bug this year, she contacted her primary care physician to get something to relieve her diarrhea. The Philadelphia resident was surprised when she received an online message informing her that because she hadn't visited her physician in more than three years, she was no longer a patient. And since he wasn't accepting new patients, she would have to find a new primary care physician.Subscribe to The Post Most newsletter for the most important and interesting stor
Mounjaro, the brand-new Type 2 diabetes therapy, brought in $187.3 million in sales in its first full quarter on the market
The actress was diagnosed with the chronic autoimmune disease in 2021.
From green to black, white to oolong, there are many types of tea. Here are the healthiest teas you can drink and the their research-backed benefits.